Left Ventricular Assist Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Left Ventricular Assist Devices Pipeline Market Report Overview
An implantable left ventricular assist device is a ventricular assist system intended for the treatment of end-stage heart failure. It assists the left ventricle by pumping oxygenated blood to the body. It can also be used to treat the right ventricle in some cases.
The Left Ventricular Assist Devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.
| Key Territories | · The United States
· Europe · Japan · India · Israel |
| Key Regulatory Paths | · 510(k)
· NMPA · CE · HSA · BOPA |
| Leading Companies | · Abbott Vascular Inc
· Abiomed Inc · APK Advanced Medical Technologies, Inc. · Arrow International Cr, A.S. · Beijing Yuewei Medical Technology Co Ltd |
| Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Left Ventricular Assist Devices Pipeline Market Segmentation by Territories
A few of the key territories with the Left Ventricular Assist Devices pipeline market are Europe, the United States, India, Japan, and Israel among others. As of August 2024, the US had the highest number of Left Ventricular Assist Devices pipeline products.
Left Ventricular Assist Devices Pipeline Market Analysis by Territories, 2024 (%)
Buy the Full Report for More Territory Insights into the Left Ventricular Assist Devices Pipeline Market
Left Ventricular Assist Devices Pipeline Market Segmentation by Regulatory Paths
A few of the key regulatory paths in the Left Ventricular Assist Devices pipeline products market are PMA, CE, NMPA, BOPA, HSA, and 510(k). As of August 2024, PMA was the most followed pathway for pipeline products in the Left Ventricular Assist Devices market.
Left Ventricular Assist Devices Pipeline Market Analysis by Regulatory Paths, 2024 (%)
Buy the Full Report for More Regulatory Path Insights into the Left Ventricular Assist Devices Pipeline Market
Left Ventricular Assist Devices Pipeline Market – Competitive Landscape
A few of the key companies associated with the Left Ventricular Assist Devices pipeline market are Abbott Vascular Inc., Abiomed Inc., APK Advanced Medical Technologies, Inc., Arrow International Cr, A.S., and Beijing Yuewei Medical Technology Co Ltd among others.
Abbott Vascular Inc: Abbott Vascular, formerly Perclose, Inc., a subsidiary of Abbott Laboratories, is a medical device company that develops manufactures, and markets cardiovascular devices. The company offers coronary intervention, peripheral intervention, and structural heart products. Its coronary intervention products include bleed back control valves, coronary dilatation catheters, coronary drug-eluting stents, coronary guide wires, and others. Abbott Vascular’s peripheral intervention products comprise peripheral guide wires, dilatation catheters, guiding catheters, and stent-grafts. The company provides minimally invasive treatment for mitral regurgitation and other structural defects of the heart. It also offers education and training services for healthcare professionals. Abbott Vascular is headquartered in Santa Clara, California, the US.
Left Ventricular Assist Devices Pipeline Market Analysis by Companies, 2024
Buy the Full Report for More Company Insights into the Left Ventricular Assist Devices Pipeline Market
Download a Free Report Sample
Segments Covered in the Report
Left Ventricular Assist Devices Pipeline Market Territories Outlook (2024)
- Europe
- The US
- India
- Japan
- Israel
Left Ventricular Assist Devices Pipeline Market Regulatory Paths Outlook (2024)
- 510(k)
- NMPA
- CE
- HSA
- BOPA
Scope
This report provides:
- Extensive coverage of the Left Ventricular Assist Devices devices under development.
- Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
- Reviews of major players involved in the development of Left Ventricular Assist Devices and lists all their pipeline projects.
- Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
- Key clinical trial data of ongoing clinical trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to Buy
- Formulate significant competitor information, analysis, and insights to improve R&D strategies.
- Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
- Identify and understand important and diverse types of Left Ventricular Assist Devices under development.
- Develop market-entry and market-expansion strategies.
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
- Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.
Abiomed Inc
APK Advanced Medical Technologies, Inc.
Arrow International Cr, A.S.
Beijing Yuewei Medical Technology Co Ltd
BioVentrix Inc
BrioHealth Solutions Inc
Calon Cardio-Technology Ltd
Cardiac Success Ltd
CardiacBooster BV
CARDIAnove Inc
Carnegie Mellon University
Chongqing Yongrenxin Medical Devices Co Ltd
Cleveland Clinic Hospital
Cleveland Heart Inc
CorAssist Cardiovascular Ltd
Corvion Inc
CorWave SA
Duke University
FineHeart
Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon
Griffith University
HeartWare International Inc
Indian Institute of Technology, Kanpur
Inspired Therapeutics LLC
Jarvik Heart Inc
LaunchPoint Technologies Inc
Leviticus Cardio Ltd
Levram Medical Systems Ltd
Magenta Medical Ltd
Mayo Clinic
Medtronic Plc
Nipro Corp
Percassist Inc
Perfusion Solution Inc
PlugMed Heart SAS
Pumpinheart Ltd
ReliantHeart, Inc.
Sree Chitra Tirunal Institute for Medical Sciences & Technology
Sun Medical Technology Research Corp
Sunshine Heart Company, Pty. Ltd.
Suzhou LungShield Medical Tech Co Ltd
Syntach AB
Thoratec LLC
Tokyo Medical and Dental University
U.S. Stem Cell Inc
University of Virginia
VASCOR Inc
Windmill Cardiovascular Systems, Inc.
W-Z BIOTECH, LLC
Yale University
Table of Contents
Table
Figures
Frequently asked questions
-
Which territory had the highest number of products in the Left Ventricular Assist Devices pipeline market as of August 2024?
As of August 2024, the US had the highest number of Left Ventricular Assist Devices pipeline products.
-
Which was the most followed regulatory pathway in the Left Ventricular Assist Devices pipeline market as of August 2024?
As of August 2024, PMA was the most followed pathway for pipeline products in the Left Ventricular Assist Devices market.
-
Which are the major companies operating in the Left Ventricular Assist Devices pipeline market?
A few of the key companies associated with the Left Ventricular Assist Devices pipeline market are Abbott Vascular Inc., Abiomed Inc., APK Advanced Medical Technologies, Inc., Arrow International Cr, A.S., and Beijing Yuewei Medical Technology Co Ltd among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Sample Report
Left Ventricular Assist Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:
- Assess the relevance of the report
- Evaluate the quality of the report
- Justify the cost
Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.
